Key result
The renin-angiotensin system plays an important role in the initiation and progression of renal cell carcinoma, with its components serving as potential diagnostic markers and therapeutic targets.
Why the study?
Developing new approaches to the diagnosis, prognosis, and treatment of RCC is a topical issue, and the role of the renin-angiotensin system in tumor progression is an active area of investigation.
The renin-angiotensin system is involved in the carcinogenesis of renal cell carcinoma, making its components potential diagnostic markers and therapeutic targets.
Hypothesis-generating for RAS modulation in renal cell carcinoma; leaves open whether targeting this pathway will.
Renal cell carcinoma (RCC) is one of the most common forms of malignant epithelial tumors of this localization. The development of new approaches to the diagnosis, prognosis and treatment of RCC is an topical issue of molecular medicine. The renin-angiotensin system (RAS) is not only an important component of the central and humoral mechanisms of controlling blood pressure and hydroelectrolytic balance, but also refers to the body systems involved in complex carcinogenesis pathways. Researches on the role of RAS in tumor progression are currently the priority. The data on the role of RAS in the development and progression of malignant tumors in the kidneys are being discussed. In this article, we present an overview of data on the role of RAS in the emergence and development of RCC, an analysis of the molecular mechanisms of development and progression of RCC, the prospects for using indicators of the RAS: angiotensin-converting enzymes (ACE), ACE2 and angiotensin II receptors as markers of diagnosis and monitoring of neoplastic transformation processes in the kidney. The prospects for the use of new, effective anticancer drugs with a targeted effect on definite indicators of the RAS of RCC were analyzed.
No takes yet. Share an insight, caveat, or question.
Коган et al. (2019) conducted a review in Renal cell carcinoma. Renin-angiotensin system components (ACE, ACE2, Ang-II receptors) was evaluated. The renin-angiotensin system plays an important role in the initiation and progression of renal cell carcinoma, with its components serving as potential diagnostic markers and therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: